Brazil's ten-year Registro rides on a two-year GMP clock

This blog has already covered how Australia's TGA pathway leans on another regulator's own review, and how Japan's pathway turns on a standard rather than a class. Brazil's ANVISA sorts devices by class the way most regimes do, and then attaches a wrinkle neither of those markets has: the credential that lets a high-risk device stay on the market runs on a longer clock than a second, separate credential underneath it — and that second credential is the one that can actually take the first one down. RDC 751/2022, in effect since 1 March 2023 and replacing the resolution that had governed Brazilian device registration for the prior two decades, is where that structure lives.

Two routes, sorted by class alone

RDC 751/2022 classifies every device into one of four risk classes — I, II, III, or IV — through twenty-two classification rules covering non-invasive, invasive, surgically invasive, active, and special-category devices, and then splits registration into two distinct procedures keyed directly to that class. Class I and II devices go through Cadastro, a notification procedure; Class III and IV devices go through Registro, a fuller registration procedure that, for equipment in those classes, also requires the manufacturing site to hold a valid Good Manufacturing Practices certificate from ANVISA. A file that logs a device's regulatory status as “ANVISA-approved” without recording which of the two procedures it went through has recorded the outcome without the pathway that produced it.

One route doesn't expire; the other does — on paper

The two procedures don't just differ in what they require going in; they differ in how long the result lasts. A Cadastro notification for a Class I or II device doesn't expire at all. A Registro for a Class III or IV device is valid for ten years from its publication in the Brazilian Federal Official Gazette, renewable for equal successive periods. Read on its own, that looks like the more durable of the two credentials, and for most of its ten years it is — until the second clock this framework runs underneath it comes due.

The GMP certificate is a separate credential, on its own schedule

The Good Manufacturing Practices certificate a Class III or IV registration depends on isn't issued once and left to run alongside the ten-year registration; ANVISA's GMP certification has its own validity period, and manufacturers of these higher-risk classes have to keep it current on a schedule measured in a couple of years, not a decade. That certificate isn't a supporting document filed once at the time of registration — it's a live credential the registration continues to depend on for as long as the registration itself remains in force, and it runs out on its own timeline regardless of how much of the ten-year registration period remains.

What happens when the two clocks fall out of sync

A Registro doesn't survive its own GMP certificate lapsing. If the certificate underneath a Class III or IV registration expires without a timely renewal, the registration it supports stops being valid too, years before its own ten-year date would otherwise have required a fresh filing. A regulatory tracker built only around the registration's own ten-year expiration date has modeled the wrong clock — the one that actually determines whether the device can keep shipping is the shorter GMP renewal cycle running underneath it, not the headline number printed on the registration itself.

Where this meets the file

A Brazil market-access tracker built around this structure needs two independent expiration fields tied to one device record, not one: the Registro or Cadastro status itself, and, for Class III and IV devices, the manufacturing site's own GMP certificate date, flagged to alert well ahead of its shorter renewal cycle rather than the registration's own distant one. A cross-jurisdiction clearance worksheet built around that split, alongside the TGA and Japan pathway logic this blog has already covered, is previewed in the launch catalog. If your program tracks ANVISA's two clocks differently, the shelf takes that correction directly.